Home  Click Here to Add a Listing  Business Solutions  Smarter AdWords Advertising Program  Disclaimer  Top 200 Categories  Contact  FAQ  Glossary
Home of SMARTER Yellow Pages For & About the San Francisco Bay Area
Always free listings...
Always
Search Tips   Current city: All Cities
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   <<< click letter to list yellow page categories
Home  >  Categories brought to you by the letter L  >  Listings under Laboratories-Pharmaceutical  >
Results: Listing for Abgenix Inc
Ray Withy, CEO
Click here to explore the website of
Abgenix Inc
(222-)
6701 Kaiser Dr  (click for map)
Fremont, CA 94555
(510) 608-6500
Click here to email
Abgenix Inc

 Abgenix is a biopharmaceutical company that develops and intends to commercialize antibody therapies for the treatment of such conditions as transplant-related diseases, inflammatory and autoimmune disorders, cardiovascular disease, infectious diseases, and cancer. Abgenix developed XenoMouseâ„¢ technology to enable the rapid generation of high affinity, fully human antibody product candidates to essentially any disease target appropriate for antibody therapy. Abgenix intends to use XenoMouse technology to build and commercialize a large and diversified product portfolio through the establishment of corporate collaborations and internal product development programs. We have collaborative arrangements with multiple pharmaceutical, biotechnology, and genomics companies involving our XenoMouse technology. In addition, we have multiple proprietary antibody product candidates under development internally, three of which are in human clinical trials for graft-versus-host disease, psoriasis, rheumatoid arthritis, and cancer.

Abgenix believes that our XenoMouse technology offers the following advantages:
  • Producing antibodies with fully human protein sequences;
  • Generating a diverse antibody response to essentially any disease target appropriate for antibody therapy;
  • Generating high affinity antibodies that do not require further engineering;
  • Enabling more effective product development; and
  • Providing flexibility in choosing manufacturing processes
  • Our objective is to be a leader in the generation, development, and commercialization of novel antibody-based biopharmaceutical products. Key elements of our strategy to accomplish this objective include the following:
  • Building a large and diversified product portfolio;
  • Leveraging XenoMouse technology through technology collaborations; and
  • Establishing collaborations for proprietary product candidates
Last Updated 5/9/00

Send SMARTERyellowpages.com your feedback (about the above Listing)
If you have different information about this Listing or were unable to contact them please let us know by clicking on the above link.
Click here to insert your Listing's URL for your Smarter AdWords Ad

Website developed, owned & operated by The Readiness Operation, Inc  |  3871 Piedmont Ave PMB 82  |  Oakland, CA 94611
Copyright 1999-2008 The Readiness Operation, Inc - All Rights Reserved - (HMS) -